Thursday, June 19th, 2025
Stock Profile: EOLS

Evolus, Inc. (EOLS)

Market: NASD | Currency: USD

Address: 520 Newport Center Drive

Evolus, Inc., a performance beauty company, focuses on delivering products in the cash-pay aesthetic market in the United States, Canada, and Europe. The company offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Nuceiva, for the temporary improvement in the appearance of moderate to severe vertical lines between the eyebrows seen at maximum frown. It also provides dermal filler products under the Estyme and Evolysse names. The company was incorporated in 2012 and is headquartered in Newport Beach, California.




📈 Evolus, Inc. Historical Chart






📊 Statistics





💰 Dividend History


No dividend history available.



📅 Earnings & EPS History for Evolus, Inc.


DateReported EPS
2026-05-05 (estimated upcoming)-
2026-03-02 (estimated upcoming)-
2025-11-04 (estimated upcoming)-
2025-11-03 (estimated upcoming)-
2025-07-29 (estimated upcoming)-
2025-07-28 (estimated upcoming)-
2025-05-07-
2025-05-05-
2025-05-04-
2025-03-04-
2025-03-040.04
2025-01-21-
2024-11-06-0.16
2024-07-31-0.04
2024-07-30-0.04
2024-05-07-0.09
2024-05-06-0.09
2024-03-07-0.12
2024-03-06-0.12
2023-11-07-0.16
2023-11-06-0.16
2023-08-02-0.19
2023-08-01-0.19
2023-05-09-0.15
2023-05-08-0.15
2023-03-08-0.14
2023-03-07-0.14
2022-11-08-0.28
2022-11-07-0.28
2022-08-02-0.28
2022-08-01-0.28
2022-05-10-0.22
2022-05-09-0.22
2022-03-03-0.22
2022-03-02-0.22
2021-11-02-0.27
2021-11-01-0.27
2021-08-04-0.19
2021-08-03-0.19
2021-05-12-0.2
2021-05-11-0.2
2021-03-24-0.44
2021-03-23-0.44
2020-10-29-0.27
2020-10-28-0.27
2020-08-10-0.43
2020-08-09-0.43
2020-05-11-0.75
2020-05-10-0.75
2020-02-24-0.47
2019-11-03-0.78
2019-08-11-1.2
2019-04-29-0.4
2019-03-17-0.46
2018-11-04-0.48
2018-08-01-0.34
2018-05-09-0.3
2018-03-28-0.28
2018-02-08-




📰 Related News & Research


No related articles found for "evolus inc".